back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-05-07 10:50 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,877
+1,010 vol $11.76 each |
51,620 | |
| Filed 2026-05-07 10:43 Tx date 2026-03-24 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+10,884 vol |
62,504 | |
| Filed 2026-03-26 16:15 Tx date 2026-03-24 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+10,844 vol |
||
| Filed 2026-03-26 16:12 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,313
+877 vol $11.76 each |
||
| Filed 2026-05-06 17:07 Tx date 2017-12-18 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-8,918
-9,800 vol $0.91 each |
34,596 | |
| Filed 2026-05-06 16:55 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-20,201 vol |
48,463 | |
| Filed 2026-05-06 16:50 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-31,862 vol |
||
| Filed 2026-05-06 16:19 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+17,103 vol |
52,017 | |
| Filed 2026-05-06 16:18 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-31,510 vol |
52,411 | |
| Filed 2026-05-06 16:14 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-15,940 vol |
50,610 | |
| Filed 2026-05-06 16:13 Tx date 2025-03-18 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+13,582 vol |
66,550 | |
| Filed 2026-05-06 16:11 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
30 - Acquisition or disposition under a purchase/ownership plan
|
+951 vol |
52,968 | |
| Filed 2026-05-06 16:10 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-18,661 vol |
34,914 | |
| Filed 2026-05-06 16:09 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
30 - Acquisition or disposition under a purchase/ownership plan
|
+1,164 vol |
53,575 | |
| Filed 2026-05-06 16:07 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-31,862 vol |
||
| Filed 2026-05-06 16:06 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+19,147 vol |
83,921 | |
| Filed 2026-05-06 16:05 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+15,182 vol |
64,774 | |
| Filed 2026-05-06 16:04 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+18,082 vol |
49,592 | |
| Filed 2026-05-06 16:03 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+31,510 vol |
31,510 | |
| Filed 2026-05-06 15:58 Tx date 2018-12-21 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$37,268
+8,375 vol $4.45 each |
591,303 |